UCB
A biopharmaceutical company focusing on discovery and development of treatments for neurology and immunology conditions
$200.0m
Money raised
Overview
A biopharmaceutical company focusing on discovery and development of treatments for neurology and immunology conditions
-
Websites:
- Business model: B2B
- Social accounts:
| Name | Phone | Social networks | |
|---|---|---|---|
| Em* Ja | - | - | - |
Industries
UCB is active in the following industries:
